Progress 06/15/11 to 02/14/12
Outputs OUTPUTS: Tuna is one of the world's most valuable commercial seafoods. The six species in the Thunnus genus (Atlantic bluefin, Southern bluefin, Pacific bluefin, albacore, yellowfin and bigeye) are considered the most popular tuna species and are the focus of this SBIR project. Increasing international demand for these high-value tuna species highlights a growing regulatory concern for proper species identification of tuna in commerce as well as stock assessment, management and conservation of these fish. Currently there are no validated diagnostics available for distinguishing all of these commercially important species of tuna. The objective of this Phase I proposal was to show proof-of-concept for a reliable and species discriminating DNA-based diagnostic that could be developed to definitely distinguish the various high value tuna species in commerce. The Outputs for the project include the following: Activities: procurement and taxonomical validation of the six most popular tuna species; conducting and analyzing experiments extracting genomic DNA, identifying and amplifying species specific gene targets, and designing primers and probes to discriminate the tuna species. Services: After this diagnostic is optimized and validated in Phase II we will utilize the diagnostic in our in-house species identification testing service. We will also train others on the use of this diagnostic. Products: The six most valued tuna species have been added to our database of taxonomically validated reference fish. Methods were developed to utilize DNA PCR and sequencing to identify these tuna species in commerce. The long term goal of this proposal is to develop a DNA diagnostic that will provide an accurate evaluation tool for tuna distributors, processors, wholesalers, retailers and government regulators for properly labeling fresh, frozen and canned tuna products. This molecular diagnostic will also be beneficial to tuna fisheries management practices and goals. Dissemination: Once Phase II is completed we will advertise that this new tuna species identification diagnostic is available. The DNA-based method will be streamlined into kit form. This kit will contain detailed sampling protocols, extraction method and materials, all test reagents and proprietary primer/probe sets. The primary end-users will be Federal and state regulatory agencies including FDA, NMFS, US Customs, State Departments of Agriculture, Environmental Protection and Natural Resource Departments. The kits will also be available to public and private laboratories and inspection services. PARTICIPANTS: Project Director, LeeAnn Applewhite, organized and directed all the key activities of the project. Applewhite established time lines for the objectives, administered the grant funds and assisted in preparing all reports. Research Scientist, Barbara Carter, designed and implemented all the research protocols for the project, thoroughly reviewed all data obtained, and closely supervised all the laboratory work. Dr. Maureen Dolan, ASU subcontract, assisted with DNA extraction protocols and development of tuna species specific primers and probes. TARGET AUDIENCES: Once the DNA diagnostic is further validated, members of the seafood industry, commercial laboratories, and Federal and State laboratories will have the first DNA based diagnostic to definitively distinguish the top value tuna species from other commercially important fish species. AFT is a leader in seafood species identification diagnostic development. All the diagnostics developed have been commercialized in testing programs for the food industry. The development of DNA based species identification diagnostics and their implementation in monitoring seafood in commerce has dramatically reduced intentional mislabeling of seafood. This tuna diagnostic will also be utilized in fishery management programs worldwide. PROJECT MODIFICATIONS: Nothing significant to report during this reporting period.
Impacts We succeeded in meeting the goals set forth in our Phase I Research Proposal technical objectives. Success achieved in the Phase I feasibility study has positioned AFT in Phase II to focus research and development efforts on final optimization of molecular diagnostic methods developed in Phase I and integrate additional commercially important species including skipjack, (Katsuwans pelamis), blackfin (Thunnus atlanticus) and Atlantic bonito (Sarda sarda) that are sold under the "tuna" label. Once optimized for fresh/frozen tuna, we will investigate modifications in DNA extraction protocols to enable the use of the diagnostic to identify tuna species in further processed tuna products (canned and pouches). Our findings in this Phase I feasibility study establishes that AFT has a scientifically sound and effective diagnostic design strategy for delivering a species discriminating DNA I.D. test for tuna. New methods and techniques were utilized that led to the success of this project. These improved technologies will be adopted and used in our testing service as well as in updated reference methods such as FDA's DNA Barcoding for Fish Species Identification. This diagnostic will address the immediate needs of the commercial seafood industry in eliminating tuna mislabeling in commerce as well as in providing a valuable tool for conservation management of one of the most endangered trade fish in the world. This project has commercialization potential for the development of user friendly test methods that can be run with minimal laboratory equipment and minimal training.
Publications
- No publications reported this period
|